共 50 条
- [1] A Genome-Wide, In Vivo, Dropout CRISPR Screen in Acute Myeloid Leukemia Identifies an Essential Role for Beta-Galactosylation in Leukemic Cell HomingBLOOD, 2017, 130Mercier, FrancoisShi, JiantaoSykes, David B.Miller, ElizabethOki, ToshihikoMan, Cheuk-HimYan, Xiao-JingKfoury, YoumnaLee, DongjunDoench, John G.Michor, FranziskaScadden, David T.
- [2] In vivo genome-wide CRISPR screening in murine acute myeloid leukemia uncovers microenvironmental dependenciesBLOOD ADVANCES, 2022, 6 (17) : 5072 - 5084Mercier, Francois E.Shi, JiantaoSykes, David B.Oki, ToshihikoJankovic, MajaMan, Cheuk HimKfoury, Youmna S.Miller, ElizabethHe, ShutaoZhu, AlexanderVasic, RadovanDoench, JohnOrthwein, AlexandreMichor, FranziskaScadden, David T.
- [3] A genome-wide CRISPR screen identifies regulators of MAPK and MTOR pathways that mediate resistance to sorafenib in acute myeloid leukemiaHAEMATOLOGICA, 2022, 107 (01) : 77 - 85Damnernsawad, AlisaBottomly, DanielKurtz, Stephen E.Eide, Christopher A.McWeeney, Shannon K.Tyner, Jeffrey W.Nechiporuk, Tamilla
- [4] An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaNATURE CANCER, 2020, 1 (04) : 410 - +Bajaj, JeevishaHamilton, MichaelShima, YutakaChambers, KendallSpinler, KyleVan Nostrand, Eric L.Yee, Brian A.Blue, Steven M.Chen, MichaelRizzeri, DavidChuah, CharlesOehler, Vivian G.Broome, H. ElizabethSasik, RomanScott-Browne, JamesRao, AnjanaYeo, Gene W.Reya, Tannishtha
- [5] An in vivo genome-wide CRISPR screen identifies the RNA-binding protein Staufen2 as a key regulator of myeloid leukemiaNature Cancer, 2020, 1 : 410 - 422Jeevisha BajajMichael HamiltonYutaka ShimaKendall ChambersKyle SpinlerEric L. Van NostrandBrian A. YeeSteven M. BlueMichael ChenDavid RizzeriCharles ChuahVivian G. OehlerH. Elizabeth BroomeRoman SasikJames Scott-BrowneAnjana RaoGene W. YeoTannishtha Reya
- [6] Genome-wide characterization of lncRNAs in acute myeloid leukemiaBRIEFINGS IN BIOINFORMATICS, 2018, 19 (04) : 627 - 635Lei, LijunXia, SiyuLiu, DanLi, XiaoqingFeng, JingZhu, YaqiHu, JunXia, LinjianGuo, LiepingChen, FeiCheng, HuiChen, KeHu, HanyangChen, XiaohuaLi, FengZhong, ShanMittal, NupurYang, GuohuaQian, ZhijianHan, LengHe, Chunjiang
- [7] An In Vivo Genome-Wide CRISPR Screen Identifies Novel Dependencies for Blast Crisis Chronic Myelogenous LeukemiaBLOOD, 2018, 132Bajaj, JeevishaScott-Browne, JamesSpinler, KyleReya, Tannishtha
- [8] A CRISPR Dropout Screen Identifies Genetic Vulnerabilities and Therapeutic Targets in Acute Myeloid LeukemiaCELL REPORTS, 2016, 17 (04): : 1193 - 1205Tzelepis, KonstantinosKoike-Yusa, HirokoDe Braekeleer, EtienneLi, YilongMetzakopian, EmmanouilDovey, Oliver M.Mupo, AnnalisaGrinkevich, VeraLi, MengMazan, MilenaGozdecka, MalgorzataOhnishi, ShuheiCooper, JonathanPatel, MitenMcKerrell, ThomasChen, BinDomingues, Ana FilipaGallipoli, PaoloTeichmann, SarahPonstingl, HannesMcDermott, UltanSaez-Rodriguez, JulioHuntly, Brian J. P.Iorio, FrancescoPina, CristinaVassiliou, George S.Yusa, Kosuke
- [9] A genome-wide CRISPR/Cas9 screen in acute myeloid leukemia cells identifies regulators of TAK-243 sensitivityJCI INSIGHT, 2021, 6 (05)Barghout, Samir H.Aman, AhmedNouri, KazemBlatman, ZacharyArevalo, KarenThomas, Geethu E.MacLean, NeilHurren, RoseKetela, TroySaini, MehakpreetAbohawya, MoustafaKiyota, TairaAl-Awar, RimaSchimmer, Aaron D.
- [10] Genome-Wide CRISPR-Cas9 Screen Identifies MicroRNAs That Regulate Myeloid Leukemia Cell GrowthPLOS ONE, 2016, 11 (04):Wallace, JaredHu, RuozhenMosbruger, Timothy L.Dahlem, Timothy J.Stephens, W. ZacRao, Dinesh S.Round, June L.O'Connell, Ryan M.